CLINICAL_TRIALS
trial_result
· 2013-01-01
Clinical Trial Update: Efficacy of Acarbose on Intestinal Microbiome and Incretins of Type 2 Diabetes [Phase 4]
Summary
Phase 4 clinical trial evaluating acarbose for type 2 diabetes, examining effects on the intestinal microbiome and incretin hormones.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Type 2 Diabetes | Phase 4 | Status: UNKNOWN